| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.036 | 0.4 |